RESUMO
In the field of endodontic therapies, the use of antibiotics, especially in the form of root canal medications, plays a pivotal role in ensuring successful treatment outcomes. This review examines the role of triple antibiotic paste (TAP) in such therapies, delving into its composition, application, and effects on endodontic infections. TAP, a combination of metronidazole, ciprofloxacin, and minocycline, targets the diverse microbial flora in odontogenic infections. Its local application within the root canal space proves more effective than systemic administration, significantly reducing microbial count and aiding in tissue regeneration and disinfection. However, the use of TAP is not without challenges, as it can cause tooth discoloration, particularly due to minocycline, and raise concerns about antibiotic resistance and long-term biocompatibility. This study, conducted through a comprehensive literature search, evaluates the efficacy of TAP, its impact on tooth structure, and its role in maintaining the vitality of diseased pulp. The findings highlight TAP’s significant role in endodontic treatments, emphasizing its benefits in achieving therapeutic goals while acknowledging the need for careful consideration of its drawbacks.
RESUMO
In years, there have been advancements in laboratory methods for detecting and monitoring cancer at its earliest stages. These breakthroughs have revolutionized the field of cancer care with a focus on treatment strategies. This review explores a range of laboratory-based approaches, including biopsies, advanced imaging technologies like PET, MRI, and CT scans, genomic profiling techniques such as next-generation sequencing novel biomarkers, innovative assay platforms, and the use of artificial intelligence-driven analytics. Liquid biopsies are particularly valuable as they provide real-time insights into tumor dynamics and responses to treatment by analyzing circulating tumor cells and cell-free DNA. Advanced imaging modalities offer enhanced sensitivity and resolution for the detection and monitoring of tumors. Genomic profiling techniques help unravel the complexities of tumors to guide therapies. Novel biomarkers show promise in types of cancer by aiding in screening prognosis determination and treatment monitoring. Innovative assay platforms allow for the analysis of biomarkers to improve diagnosis. The integration of intelligence (AI) and machine learning has been instrumental in interpreting clinical and molecular data alongside traditional laboratory techniques. However, despite progress made far challenges related to standardization, cost effectiveness, and ethical considerations persist. It is crucial to integrate these techniques into clinical practice to fully exploit their potential in enhancing cancer care.